About this episode
Tests on patients for up to 8 months following their infection with SARS- CoV-2 suggests an immune response can persist. Alessandro Sette and Daniela Weiskopf at the La Jolla Institute in California are optimistic this could mean vaccines would also confer long lasting immunity.
An analysis of samples from Kenya’s blood banks by Sophie Uyoga at the KEMRI-Wellcome Research Programme reveals far more people in Kenya contracted the virus than was previously know. The figures mean Kenya has similar levels of infection to many European countries.
And a study of mosquitoes by Louis Lambrechts of the Pasteur Institute in Paris reveals why Zika, a virus originating in Africa is much more prevalent in other parts of the world.
We also look at the future of the Nile. Ethiopia is building a massive Dam which will have consequences for Sudan and Egypt who are reliant on the Nile’s waters says hydrologist Hisham Eldardiry from the University of Washington, Seattle.
(Image: Credit: Getty Images)
Presenter: Roland Pease Producer: Julian Siddle
Get every episode summarized
Each time Science In Action publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Science In Action
How science got here, and where next
Science In Action
Coral extinctions and chalky unknowns
Science In Action
Paris agreement impacts and drought realities
Science In Action
Old faces and big spaces in small places
Science In Action